Roth/MKM Reiterates Buy Rating on Aspen Aerogels (ASPN)

Roth/MKM analyst Chip Moore reiterated a Buy rating and $36.00 price target on Aspen Aerogels (NYSE: ASPN).

The analyst comments "We reiterate our Buy rating and $36 target ahead of expected positive catalysts. We favor current positioning, including a clear focus on profitable growth as management positions the portfolio for what we view as a strong secular opportunity. We believe that 2024 represents a key inflection point, with Aspen poised to demonstrate positive net income and significant growth for its thermal barrier products (despite the broader EV macro backdrop). We anticipate outperformance as profitability continues to ramp with asset utilization."

For an analyst ratings summary and ratings history on Aspen Aerogels click here. For more ratings news on Aspen Aerogels click here.

Shares of Aspen Aerogels closed at $31.72 yesterday.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• CORVEX (MOVE) files for 53.39M share offering by selling stockholders
• Faraday Future registers up to 62M shares for resale